Combined Naples Prognostic Score and PhenoAge acceleration

Biomarker

1 paper2 findings

  • Humans1

Effects

1

Predictive performance for poor functional outcomes

upin humans1

1 study
  1. Combined Naples Prognostic Score and PhenoAge acceleration improves predictive performance for poor functional outcomes in humans.

    “Incorporating combined NPS and PAA into the basic model improved predictive performance for short- and long-term poor functional outcomes.”

    HumansAddition to the basic model in patients with acute ischemic stroke or transient ischemic attack3 months and 1 yearn = 7,932

    Association of the Naples Prognostic Score With Functional Outcomes and the Mediating Effects of PhenoAge Acceleration in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Nationwide Registry Study

    Journal of the American Heart Association30 Jan 2026

Associations

1

Poor functional outcomes

upin humans1OR 2.16

1 study
  1. Combined Naples Prognostic Score and PhenoAge acceleration is associated with poor functional outcomes in humans (Adjusted OR 2.16, 95% CI 1.73–2.70).

    “Patients with both high NPS and PAA ≥0 had the highest risks of poor outcomes (adjusted OR, 2.16 [95% CI, 1.73-2.70] for mRS 3-6;”

    HumansAcute ischemic stroke or transient ischemic attack; high NPS and PhenoAge acceleration ≥03 monthsn = 7,932

    Association of the Naples Prognostic Score With Functional Outcomes and the Mediating Effects of PhenoAge Acceleration in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Nationwide Registry Study

    Journal of the American Heart Association30 Jan 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months